rQNestin
16-557
Phase 1 small_molecule active
Quick answer
rQNestin for Malignant Glioma of Brain is a Phase 1 program (small_molecule) at Candel Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Candel Therapeutics
- Indication
- Malignant Glioma of Brain
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active